Driving CAR-T therapy safety and sustainability for the road ahead

Q&A with Abby McDonald, PhD, Solutions Development Supervisor

An opportunity to impact the future of medicine

As told by Leah, Be The Match BioTherapies® allogeneic donor

The benefits of a Quality System Audit Program

Accelerate patient access to cell and gene therapies

Standardization in cell therapy industry is a race against time

Accellerate Summit highlights needs and challenges in standardization

The challenge of multiple audits and redundant training

A case study from UCLA Health

Developing and managing a strong collection center network

On-demand webinar available

Industry stakeholders propose unified CAR T toxicity grading scale

CIBMTR Cellular Therapy Registry recommended to meet outcomes data reporting requirements

‘There is no room for error’ in cell and gene therapy logistics

Delivering life-saving therapies on time, every time

Advancements in Cell Therapy: 2018 Year-In-Review